For years, people from CEOs to novelists have taken tiny amounts of psychedelics to support well-being. New research shows ...
Hosted on MSN
LSD microdosing reduces depression scores without major side effects, clinical trial finds
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...
Psilocybin, a classic psychedelic, has therapeutic potential for psychiatric disorders. A specific brain circuit and receptor have now been found to be required for psilocybin’s long-term effects on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results